Recent Finacing
Recent Raise
Orgenesis is a development-stage biotech developing cellular trans-differentiation to convert autologous liver cells into insulin-producing cells, operating a Belgian subsidiary and partnering on bioreactor manufacturing for clinical trials.
Focus Areas
Funding round